Pharma Journalist -

Opna Bio, a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, has received a key regulatory boost for its myelofibrosis program. The U.S. Food and…
Read More...

Novo Nordisk and Aspect Biosystems have announced the expansion of their strategic partnership, entering a new phase focused on developing advanced cellular medicines for diabetes that…
Read More...

Bristol Myers Squibb (BMS) has entered into a strategic collaboration with Microsoft to accelerate the early detection of lung cancer by integrating advanced artificial intelligence…
Read More...

GSK plc and Japan-based pharmaceutical company Shionogi & Co., Ltd. have reached an agreement, alongside Pfizer Inc., to reshape the ownership structure of ViiV Healthcare, the…
Read More...

AstraZeneca has agreed to acquire AbelZeta Pharma’s remaining stake in the China development and commercialization rights to C-CAR031, consolidating full global control of the…
Read More...

iRegene Therapeutics has reached a major regulatory milestone with its lead program for Parkinson’s disease, as the U.S. Food and Drug Administration granted Regenerative Medicine…
Read More...

Novartis has received a significant regulatory boost for its autoimmune disease pipeline after the U.S. Food and Drug Administration granted Breakthrough Therapy designation to…
Read More...

AstraZeneca has acquired Modella AI, a life sciences–focused artificial intelligence company, in a move that deepens the companies’ existing collaboration and strengthens AstraZeneca’s…
Read More...

Agenus Inc. has completed the closing of its previously announced strategic collaboration with Zydus Lifesciences Ltd., a move aimed at accelerating the global development and potential…
Read More...

The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have jointly agreed on ten principles for good artificial intelligence (AI) practice across the…
Read More...